Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations
An optimized method for mass spectrometry based immunopeptidomics analysis using high-field asymmetric waveform ion mobility spectrometry is presented and identifies 44,815 HLA-bound peptides (HLAp) from colorectal cancer samples.
Main Authors: | Yuriko Minegishi, Kazuma Kiyotani, Kensaku Nemoto, Yoshikage Inoue, Yoshimi Haga, Risa Fujii, Naomi Saichi, Satoshi Nagayama, Koji Ueda |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-022-03807-w |
Similar Items
-
Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3
by: Tomohiro Tate, et al.
Published: (2023-02-01) -
149 Simultaneous identification of KRAS mutation-carrying multiple neoepitopes by differential ion mobility-assisted targeted-mass spectrometry
by: William L Redmond, et al.
Published: (2023-11-01) -
An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens
by: Niclas Olsson, et al.
Published: (2021-04-01) -
Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome
by: Scott D. Brown, et al.
Published: (2019-03-01) -
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
by: Alice Newey, et al.
Published: (2019-11-01)